Period
recent search
Showing: 1 – 05 of 156 Regulated Information
Ipsen to acquire ImCheck Therapeutics, expanding its leadership in oncology, strengthening its pipeline
PARIS AND MARSEILLE, FRANCE, 22 October 2025 – Ipsen (Euronext: IPN; ADR: IPSEY) and ImCheck Therapeutics today announced they have entered into a definitive share purchase agreement in which Ipsen will acquire all issued and outstanding shares of ImCheck Therapeutics,…
Ipsen – September 2025 – Monthly information relative to the total number of voting rights and shares composing the share capital
Monthly information relative to the total number of voting rights and shares composing the share capital
